{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T18:57:53Z","timestamp":1648666673867},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/md.0000000000001091","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T21:31:30Z","timestamp":1436650290000},"page":"e1091","source":"Crossref","is-referenced-by-count":1,"title":["Delimiting Allelic Imbalance of TYMS by Allele-Specific Analysis"],"prefix":"10.1097","volume":"94","author":[{"given":"Emilia","family":"Balboa-Beltr\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Carracedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-30-20210226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.tpj.6500012","article-title":"Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy.","volume":"1","author":"Pullarkat","year":"2001","journal-title":"Pharmacogenomics J"},{"key":"R2-30-20210226","first-page":"2898","article-title":"A novel single nucleotide polymorphism within the 5 tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity.","volume":"63","author":"Mandola","year":"2003","journal-title":"Cancer Res"},{"key":"R3-30-20210226","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1247\/csf.20.191","article-title":"Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5-terminal regulatory region of the human gene for thymidylate synthase.","volume":"20","author":"Horie","year":"1995","journal-title":"Cell Struct Funct"},{"key":"R4-30-20210226","first-page":"4096","article-title":"Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.","volume":"7","author":"Kawakami","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R5-30-20210226","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/tpj.2010.43","article-title":"Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo.","volume":"11","author":"de Bock","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"R6-30-20210226","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2217\/pgs.10.170","article-title":"Detection of the G C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresis.","volume":"11","author":"Thomas","year":"2010","journal-title":"Pharmacogenomics"},{"key":"R7-30-20210226","first-page":"6004","article-title":"Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.","volume":"63","author":"Kawakami","year":"2003","journal-title":"Cancer Res"},{"key":"R8-30-20210226","first-page":"484","article-title":"The association of thymidylate synthase mRNA expression with its three gene polymorphisms in colorectal cancer.","volume":"64","author":"Kawakami","year":"2004","journal-title":"Cancer research"},{"key":"R9-30-20210226","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00008571-200405000-00007","article-title":"A 6bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels.","volume":"14","author":"Mandola","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R10-30-20210226","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3109\/10428194.2011.649477","article-title":"Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis.","volume":"53","author":"Weng","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"R11-30-20210226","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00384-011-1258-9","article-title":"Association of OGG1 Ser326Cys polymorphism with colorectal cancer risk: a meta-analysis.","volume":"26","author":"Zhang","year":"2011","journal-title":"Int J Colorectal Dis"},{"key":"R13-30-20210226","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(02)08065-0","article-title":"Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia.","volume":"359","author":"Krajinovic","year":"2002","journal-title":"Lancet"},{"key":"R14-30-20210226","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.leukres.2011.04.007","article-title":"Polymorphism of the thymidylate synthase gene and risk of relapse in childhood ALL.","volume":"35","author":"Pietrzyk","year":"2011","journal-title":"Leuk Res"},{"key":"R15-30-20210226","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/AAC.01589-10","article-title":"Association of thymidylate synthase gene polymorphisms with stavudine triphosphate intracellular levels and lipodystrophy.","volume":"55","author":"Domingo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-30-20210226","doi-asserted-by":"crossref","first-page":"e57347","DOI":"10.1371\/journal.pone.0057347","article-title":"Association of thymidylate synthase polymorphisms with acute pancreatitis andor peripheral neuropathy in HIV-infected patients on stavudine-based therapy.","volume":"8","author":"Domingo","year":"2013","journal-title":"PloS One"},{"key":"R17-30-20210226","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2010.09.053","article-title":"X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients.","volume":"82","author":"Lamas","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-30-20210226","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00432-010-0826-7","article-title":"Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil.","volume":"136","author":"Paez","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"R19-30-20210226","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.ijrobp.2011.01.025","article-title":"Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.","volume":"81","author":"Paez","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-30-20210226","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.1998.16.4.1470","article-title":"Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.","volume":"16","author":"Gamelin","year":"1998","journal-title":"J Clin Oncol"},{"key":"R21-30-20210226","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2217\/pgs.10.188","article-title":"Systems pharmacology assessment of the 5-fluorouracil pathway.","volume":"12","author":"Muhale","year":"2011","journal-title":"Pharmacogenomics"},{"key":"R22-30-20210226","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/1471-2407-13-369","article-title":"MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells.","volume":"13","author":"Gotanda","year":"2013","journal-title":"BMC Cancer"},{"key":"R23-30-20210226","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.0308716101","article-title":"Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients.","volume":"101","author":"Wang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-30-20210226","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0006-2952(95)00067-A","article-title":"Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil.","volume":"49","author":"Copur","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"R25-30-20210226","first-page":"986","article-title":"Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil.","volume":"7","author":"Showalter","year":"2008","journal-title":"Is it time to move forward Cancer Biol Ther"},{"key":"R26-30-20210226","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4161\/cbt.12.8.16867","article-title":"Reexamining a proposal: thymidylate synthase 5-untranslated region as a regulator of translation efficiency.","volume":"12","author":"Ghosh","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"R27-30-20210226","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1200\/JCO.2010.32.3212","article-title":"Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.","volume":"29","author":"Tan","year":"2011","journal-title":"J Clin Oncol"},{"key":"R28-30-20210226","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000320464","article-title":"Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer.","volume":"78","author":"Carlomagno","year":"2010","journal-title":"Oncology"},{"key":"R29-30-20210226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjc.6604131","article-title":"Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy.","volume":"98","author":"Negri","year":"2008","journal-title":"Br J Cancer"},{"key":"R30-30-20210226","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2008.07.008","article-title":"Thymidylate synthase genotypes and tumour regression in stage IIIII rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation.","volume":"272","author":"Stoehlmacher","year":"2008","journal-title":"Cancer Lett"},{"key":"R31-30-20210226","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/codi.12009","article-title":"Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy.","volume":"15","author":"Arrazubi","year":"2013","journal-title":"Colorectal Dis"},{"key":"R32-30-20210226","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/mp.55.5.310","article-title":"Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines.","volume":"55","author":"Derenzini","year":"2002","journal-title":"Mol Pathol"},{"key":"R33-30-20210226","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/nar\/22.3.427","article-title":"Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells.","volume":"22","author":"Sirito","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"R34-30-20210226","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of real-time quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemiaa Europe Against Cancer program.","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"R35-30-20210226","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2217\/pgs.10.51","article-title":"Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.","volume":"11","author":"Balboa","year":"2010","journal-title":"Pharmacogenomics"},{"key":"R38-30-20210226","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"key":"R39-30-20210226","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrg2957","article-title":"Enhancer function: new insights into the regulation of tissue-specific gene expression.","volume":"12","author":"Ong","year":"2011","journal-title":"Nat Rev Genet"},{"key":"R40-30-20210226","doi-asserted-by":"crossref","first-page":"20222","DOI":"10.1073\/pnas.0902454106","article-title":"Transcription factors mediate long-range enhancer-promoter interactions.","volume":"106","author":"Nolis","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R41-30-20210226","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.tig.2010.08.003","article-title":"Gene regulation by nucleosome positioning.","volume":"26","author":"Bai","year":"2010","journal-title":"Trends Genet"},{"key":"R42-30-20210226","doi-asserted-by":"crossref","first-page":"e59689","DOI":"10.1371\/journal.pone.0059689","article-title":"Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines.","volume":"8","author":"Luca","year":"2013","journal-title":"PLoS One"},{"key":"R43-30-20210226","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1534\/g3.113.005777","article-title":"The genomic and transcriptomic landscape of a HeLa cell line.","volume":"3","author":"Landry","year":"2013","journal-title":"G3 (Bethesda)"},{"key":"R44-30-20210226","first-page":"1407","article-title":"Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.","volume":"55","author":"Johnston","year":"1995","journal-title":"Cancer Res"},{"key":"R45-30-20210226","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3816\/CCC.2009.n.024","article-title":"Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.","volume":"8","author":"Mauritz","year":"2009","journal-title":"Clin Colorectal Cancer"},{"key":"R46-30-20210226","first-page":"786","article-title":"Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.","volume":"9","author":"Ichikawa","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R47-30-20210226","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/jme.0.0250169","article-title":"Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.","volume":"25","author":"Bustin","year":"2000","journal-title":"J Mol Endocrinol"},{"key":"R48-30-20210226","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.leu.2402133","article-title":"Current recommendations for positive controls in RT-PCR assays.","volume":"15","author":"Lion","year":"2001","journal-title":"Leukemia"},{"key":"R49-30-20210226","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","article-title":"Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications.","volume":"12","author":"Tsiatis","year":"2010","journal-title":"J Mol Diagn"},{"key":"R50-30-20210226","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2144\/000113913","article-title":"Improving the limit of detection for Sanger sequencing: a comparison of methodologies for KRAS variant detection.","volume":"53","author":"Davidson","year":"2012","journal-title":"Biotechniques"},{"key":"R51-30-20210226","first-page":"2455","article-title":"Thymidylate synthetase (TS) genotype and TSdihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.","volume":"24","author":"Toriumi","year":"2004","journal-title":"Anticancer Res"},{"key":"R52-30-20210226","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.bjc.6601523","article-title":"Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity.","volume":"90","author":"Etienne","year":"2004","journal-title":"Br J Cancer"},{"key":"R53-30-20210226","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/FPC.0b013e328351875d","article-title":"Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis.","volume":"22","author":"Jennings","year":"2012","journal-title":"Pharmacogenetics Genomics"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:46:06Z","timestamp":1620960366000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201507020-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":50,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001091","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}